Premature ventricular contraction prevention
Premature ventricular contraction Microchapters |
Differentiating Premature Ventricular Contraction from other Disorders |
---|
Diagnosis |
Treatment |
Case Studies |
Premature ventricular contraction prevention On the Web |
to Hospitals Treating Premature ventricular contraction prevention |
Risk calculators and risk factors for Premature ventricular contraction prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]
Recommendations for Secondary Prevention of SCD in Patients With Ischemic Heart Disease
Class I |
1. CPR should be performed in patients in cardiac arrest according to published basic and advanced cardiovascular life support algorithms (Level of Evidence: A).[1][2][3]
2. In patients with hemodynamically unstable VA that persist or recur after a maximal energy shock, intravenous amiodarone should be administered to attempt to achieve a stable rhythm after further defibrillation (Level of Evidence: A). [1][4][5] 3. Patients presenting with VA with hemodynamic instability should undergo direct current cardioversion (Level of Evidence: A).[1][2][3]
|
References
- ↑ 1.0 1.1 1.2 Link, Mark S.; Berkow, Lauren C.; Kudenchuk, Peter J.; Halperin, Henry R.; Hess, Erik P.; Moitra, Vivek K.; Neumar, Robert W.; O’Neil, Brian J.; Paxton, James H.; Silvers, Scott M.; White, Roger D.; Yannopoulos, Demetris; Donnino, Michael W. (2015). "Part 7: Adult Advanced Cardiovascular Life Support". Circulation. 132 (18 suppl 2): S444–S464. doi:10.1161/CIR.0000000000000261. ISSN 0009-7322.
- ↑ 2.0 2.1 Stiell, Ian G.; Wells, George A.; Field, Brian; Spaite, Daniel W.; Nesbitt, Lisa P.; De Maio, Valerie J.; Nichol, Graham; Cousineau, Donna; Blackburn, Josée; Munkley, Doug; Luinstra-Toohey, Lorraine; Campeau, Tony; Dagnone, Eugene; Lyver, Marion (2004). "Advanced Cardiac Life Support in Out-of-Hospital Cardiac Arrest". New England Journal of Medicine. 351 (7): 647–656. doi:10.1056/NEJMoa040325. ISSN 0028-4793.
- ↑ 3.0 3.1 Sasson, Comilla; Rogers, Mary A.M.; Dahl, Jason; Kellermann, Arthur L. (2010). "Predictors of Survival From Out-of-Hospital Cardiac Arrest". Circulation: Cardiovascular Quality and Outcomes. 3 (1): 63–81. doi:10.1161/CIRCOUTCOMES.109.889576. ISSN 1941-7713.
- ↑ Dorian, Paul; Cass, Dan; Schwartz, Brian; Cooper, Richard; Gelaznikas, Robert; Barr, Aiala (2002). "Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular Fibrillation". New England Journal of Medicine. 346 (12): 884–890. doi:10.1056/NEJMoa013029. ISSN 0028-4793.
- ↑ P. J. Kudenchuk, L. A. Cobb, M. K. Copass, R. O. Cummins, A. M. Doherty, C. E. Fahrenbruch, A. P. Hallstrom, W. A. Murray, M. Olsufka & T. Walsh (1999). "Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation". The New England journal of medicine. 341 (12): 871–878. doi:10.1056/NEJM199909163411203. PMID 10486418. Unknown parameter
|month=
ignored (help)